Status:
COMPLETED
Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications
Lead Sponsor:
University of Pittsburgh
Conditions:
Chronic Pain
Depression, Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators are conducting a comparative effectiveness trial among adult patients with sickle cell disease (SCD) who report chronic pain (N = 350), randomized to receive either mobile phone-deli...
Detailed Description
CaRISMA is a randomized comparative effectiveness trial among adult patients with SCD who report chronic pain (N = 350) randomized to receive either cCBT (n = 175) or m-Education (n = 175). A third gr...
Eligibility Criteria
Inclusion
- People with any type of sickle cell disease
- Male or female, age 18 years or older
- Reports chronic pain: i.e pain more days that not for the past 3 months or longer and/or is prescribed daily or long-acting opioids for pain.
- English speaking
Exclusion
- Any potential participants who fail consent comprehension questions
Key Trial Info
Start Date :
August 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2023
Estimated Enrollment :
359 Patients enrolled
Trial Details
Trial ID
NCT04419168
Start Date
August 12 2020
End Date
December 11 2023
Last Update
February 19 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinous-Chicago
Chicago, Illinois, United States, 60607
2
Johns Hopkins
Baltimore, Maryland, United States, 21287
3
Duke University
Durham, North Carolina, United States, 27708
4
East Carolina University
Greenville, North Carolina, United States, 27858